This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Gram-Negative Bacterial Infections
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to evaluate the PK/PD parameters, safety and efficacy of extended infusion of beta-lactams in intensive care patients who are infected with Gram-negative bacteremia or pneumonia at National Taiwan University Hospital (NTUH).

Provided treatments

  • Drug: Beta-Lactams
  • Drug: Beta-Lactams

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01600768. The sponsor of the trial is National Taiwan University Hospital and it is looking for 100 volunteers for the current phase.
Official trial title: